<?xml version="1.0" encoding="UTF-8"?>
<ref id="JVEv5-bib-0021">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Deuffic-Burban</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Schwarzinger</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Obach</surname>
    <given-names>D</given-names>
   </name>
   <etal>et al.</etal>
  </person-group>
  <article-title>Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)</article-title>. 
  <source>J Hepatol</source>
  <year>2014</year>; 
  <volume>61</volume>: 
  <fpage>7</fpage>â€“ 
  <lpage>14</lpage>.
  <pub-id pub-id-type="pmid">24650691</pub-id>
 </mixed-citation>
</ref>
